comparemela.com

Latest Breaking News On - Coronary revascularization - Page 1 : comparemela.com

Results of CERTAIN Study Demonstrate Prominent Effects of Cleerly Products on Changing Clinical Management for Patients Suspected of Coronary Artery Disease

Cleerly, Inc., a digital healthcare company focused on AI-driven heart disease diagnosis, has announced continued strong scientific evidence supporting the clinical utility of its products, detailing a study published online in the European Heart Journal Cardiovascular Imaging.

United statesComunidad autonoma de catalunaJamesp earlsJames earlsGonzalez quesadaUdo hoffmanSociety of cardiovascular computed tomographyEuropean heart journal cv imagRadiology at george washington universityLate breaking clinical researchAmerican society of cardiac imagingCleerly incFellows of the society cardiovascularEuropean association of cardiovascular imagingEuropean heart journal cardiovascularDiagnostic certainty

Philips Showcases Latest Medical Innovations and Solutions for Patients with Cardiovascular Disease TCT23

Published late-breaking clinical data presented at TCT 2023

United statesSan franciscoBert van meursColl cardiolNational registryCatheterization lab at skane university hospitalMoscone centerTranscatheter cardiovascular therapeuticsPhilips engagement hubChief business leaderImage guided therapyCardiac catheterization labSkane university hospitalLong term clinical outcomes afterCoronary revascularizationInsights from

TCT23 Late-breakers: Full Schedule Announced

Late-breaking trials will be presented during the main sessions and highlighted during press conferences scheduled for Oct. 24, 25 and 26

United statesSan franciscoSuzannev arnoldDavide kandzariRobertl smithDavidh adamsAmitn voraSusheelk kodaliJoanna chikweSuzannej baronFiras zahrAnitaw asgarTobias kochMirvat alasnagRoberto bonowRobertw yeh

Mount Sinai to launch $30M trial to study coronary procedures in women, minorities

Mount Sinai receives $30 million in funding to study which coronary revascularization procedure best improves survival and quality of life for women and minority populations.

Outcomes research instituteMount sinai health systemNew york city based icahn schoolMount sinaiPatient centered outcomes research instituteWeill cornellGregg stoneHeart diseaseIcahn school of medicineMount sinaiCoronary revascularizationPatient centered outcomes research instituteWeill cornell medicineWhite menGregg stone

Big Reductions in ASCVD Events With Bempedoic Acid in Primary Prevention

While there can be a debate over the effect size, or the reduction in mortality, experts say the drug fills an unmet need.

United statesBaylor college of medicineSteven nissenDhruv kaziSalim viraniMichael blahaMd johns hopkins universityMd baylor college of medicineAga khan universityCleveland clinicJohns hopkins universityBaylor collegeNonfatal strokeCoronary revascularizationUnstable angina

vimarsana © 2020. All Rights Reserved.